Revolution Medicines Inc

1RVMD

Company Profile

  • Business description

    Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

  • Contact

    700 Saginaw Drive
    Redwood CityCA94063
    USA

    T: +1 650 481-6801

    https://www.revmed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    700

Stocks News & Analysis

stocks

Are small caps finally back?

Does renewed investor interest point to a structural shift in the underperforming factor?
stocks

Chart of the Week: Modest earnings growth at odds with overvalued bank shares

The latest update from our Industry Pulse report.
stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,317.2039.000.42%
CAC 408,206.8751.99-0.63%
DAX 4024,151.13178.90-0.74%
Dow JONES (US)46,590.41334.33-0.71%
FTSE 1009,533.90106.911.13%
HKSE25,725.2456.53-0.22%
NASDAQ22,740.40213.27-0.93%
Nikkei 22548,731.51576.28-1.17%
NZX 50 Index13,343.9337.490.28%
S&P 5006,699.4035.95-0.53%
S&P/ASX 2009,021.9035.700.40%
SSE Composite Index3,900.1713.58-0.35%

Market Movers